1. An Evaluation of Risk Factors for Major Adverse Cardiovascular Events During Tocilizumab Therapy. Issue 2 (February 2015) Authors: Rao, Vijay U.; Pavlov, Andrey; Klearman, Micki; Musselman, David; Giles, Jon T.; Bathon, Joan M.; Sattar, Naveed; Lee, Janet S. Journal: Arthritis & rheumatology Issue: Volume 67:Issue 2(2015) Page Start: 372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial. Issue 1 (27th December 2019) Authors: Giles, Jon T.; Sattar, Naveed; Gabriel, Sherine; Ridker, Paul M.; Gay, Steffen; Warne, Charles; Musselman, David; Brockwell, Laura; Shittu, Emma; Klearman, Micki; Fleming, Thomas R. Journal: Arthritis & rheumatology Issue: Volume 72:Issue 1(2020) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗